Agfa names leadership for combined businessesAgfa’s integration of Sterling Diagnostic Imaging has begun to move forward. The company has appointed its North American management team for the combined Sterling and Agfa businesses. Former
Agfas integration of Sterling Diagnostic Imaging has begun to move forward. The company has appointed its North American management team for the combined Sterling and Agfa businesses. Former Sterling employees are well represented.
Sterling COO Ernest Waaser has been named senior vice president of North America, replacing John Glass, who is now managing director of Agfas worldwide medical imaging business.
Sterling senior vice president for Americas Robert Pryor has been tapped as vice president of North American sales, handling field sales, national accounts, and the companys efforts in the U.S. militarys Digital Imaging Network-Picture Archiving and Communications Systems (DIN-PACS) project.
Agfa veteran Robert Cooke has been named vice president of Impax Solutions, continuing his previous responsibilities for product management, marketing, and professional services for the PACS and CR businesses. Michael Sullivan has been appointed vice president of customer support. He has handled similar responsibilities for Agfa.
Sterling executive director of worldwide marketing William Ward will head up marketing communications and strategy, while John Wilkens will lead the firms business development efforts. Wilkens had previously served as vice president of Sterlings Imaging Media Systems business.
Finally, Agfa has received a $5.6 million PACS and CR contract from Elmhurst Hospital Center in Elmhurst, NY. Agfa expects to complete installation at the 500-bed hospital in late September.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.